GB9208135D0 — Polypeptides having kinase activity,their preparation and use
Assigned to Ludwig Institute for Cancer Research Ltd · Expires 1992-05-27 · 34y expired
What this patent protects
This invention relates to new polypeptides which exhibit kinase activity or, more specifically, which show phosphoinositide (PI)3-kinase activity. Such polypeptides are involved in pathways responsible for cellular growth and differentiation. An isolated polypeptide which possess…
USPTO Abstract
This invention relates to new polypeptides which exhibit kinase activity or, more specifically, which show phosphoinositide (PI)3-kinase activity. Such polypeptides are involved in pathways responsible for cellular growth and differentiation. An isolated polypeptide which possesses PI3-kinase activity when produced by recombinant production in insect cells is disclosed.
Drugs covered by this patent
- Itovebi (INAVOLISIB) · Genentech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.